Rex, J.H., Pappas, P.G. and Karchmer, A.W. (2003) A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus ampho- tericin B as therapy for candidemia and its conse-quences in nonneutropenic subjects. Clinical Infectious Diseases, 36, 1221-1228.

has been cited by the following article:

• TITLE: Treatment of pulmonary coccidioidomycosis after successful hepatitis C therapy in a patient with fluconazole induced hepatotoxicity

  AUTHORS: Zohreh Movahedi, David Wisinger, Sorin Petre, Jyotsna Ravi, Thomas Ardiles, Renee Prevette, Ali Al-Yaqoobi, Abdul Nadir

  KEYWORDS: Coccidioidomycosis, Fluconazole, Hepatotoxicity

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.2 No.1, February 16, 2012

  ABSTRACT: A patient with hepatitis C infection and cavitary pul- monary coccidioidomycosis is reported. Treatment of hepatitis C was associated with resolution of flucona- zole-induced hepatotoxicity. Successful treatment of he- patitis C enabled the patient to tolerate increaseing doses of fluconazole. This case highlights that hepatic toxicity of fluconazole can improve after successful treatment of hepatitis C.